# A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma

> **NCT00002314** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche**

## Conditions studied

- Sarcoma, Kaposi
- HIV Infections

## Interventions

- **DRUG:** Ro 24-7429

## Key facts

- **NCT ID:** NCT00002314
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002314, "A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*